The role of the FDA, its regulatory processes, and the hurdles faced in getting approval for longevity drugs are extensively discussed.
The episode mentions the FDA's regulations on the approved uses of sensors on the Apple Watch, which is a relevant topic in the context of its medical applications.
The episode examines the FDA's regulatory process for approving and overseeing medications like mifepristone, and the implications of the court's decision for this process.
The FDA's standards for what qualifies as 'real' chocolate are briefly mentioned.
The FDA plays a central role in the podcast episodes, which discuss various aspects of its regulations and approval processes.
Several episodes touch on the FDA's oversight of emerging technologies like the Apple Watch and Neuralink's brain-chip implantation, as well as its regulation of drugs and natural remedies, including mifepristone, compounded medications, and fecal transplants.
The episodes also explore how the FDA's standards and decision-making can impact industries like weight-loss drugs and the chocolate industry.